SCHEMBL30183103

SCHEMBL30183103

CNC(=O)c1ccc(NC(=O)c2n[nH]c3c2C(C)(C)Cc2cnc(N)nc2-3)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 2/20 0.43
PRKDC P78527 1/20 0.40
ATM Q13315 1/20 0.40
ATR Q13535 1/20 0.40
CDK2 P24941 15/20 0.39
CCNA2 P20248 7/20 0.39
CDK4 P11802 2/20 0.39
CDK6 Q00534 2/20 0.39
CCND3 P30281 1/20 0.39
AURKA O14965 8/20 0.39
KIT P10721 3/20 0.38
PDGFRB P09619 2/20 0.38
GAK O14976 1/20 0.38
BUB1 O43683 1/20 0.38
CCNT1 O60563 1/20 0.38
ULK1 O75385 1/20 0.38
STK16 O75716 1/20 0.38
PRKD3 O94806 1/20 0.38
LATS1 O95835 1/20 0.38
ABL1 P00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20648935 1.00 FLT3 (0.43) FLT3PRKDCATMATRCDK2
SCHEMBL20648961 0.92 RARA (0.44) ATRCDK2CCNA2CDK4CDK6
SCHEMBL30183938 0.92 RARA (0.44) ATRCDK2CCNA2CDK4CDK6
SCHEMBL20648989 0.90 PRKCI (0.39) FLT3PRKDCATMATRCDK2
SCHEMBL30183109 0.90 PRKCI (0.39) FLT3PRKDCATMATRCDK2
SCHEMBL20649197 0.90 PDGFRB (0.41) FLT3ATRCDK2CCNA2CDK4
SCHEMBL20649055 0.90 ATR (0.43) ATRCDK2CCNA2KITPDGFRB
SCHEMBL30183118 0.90 ATR (0.43) ATRCDK2CCNA2KITPDGFRB
SCHEMBL20649357 0.88 ATR (0.40) ATRCDK2CCNA2KITKDR
SCHEMBL20649010 0.88 ATR (0.40) ATRCDK2CCNA2AURKAKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 CN claimed
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 CN disclosed